Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants (2025)
- Authors:
- Daher, Isabela Pazotti
- Almeida, Bianca da Silva
- Souza-Silva, Guilherme Antonio de
- Marques, Rodolfo Ferreira
- Soares, Gustavo Henrique Corrêa
- Andreata-Santos, Robert
- Moretti, Ana
- Silva, Mariângela de Oliveira
- Schuch, Viviane
- Sasahara, Greyce Luri
- Kuramoto, Andréia
- Yamamoto, Márcio
- Santos, Keity
- Coelho, Veronica Porto Carreiro de Vasconcellos
- Kalil Filho, Jorge Elias
- Rosa, Daniela Santoro
- Cunha Neto, Edecio
- Ferreira, Luís Carlos de Souza
- Boscardin, Silvia Beatriz
- Daher, Isabela Pazotti
- USP affiliated authors: YAMAMOTO, MARCIO MASSAO - ICB ; SANTOS, KEITY SOUZA - FM ; KALIL FILHO, JORGE ELIAS - FM ; CUNHA NETO, EDECIO - FM ; FERREIRA, LUIS CARLOS DE SOUZA - ICB ; BOSCARDIN, SILVIA BEATRIZ - ICB ; DAHER, ISABELA PAZOTTI - FM ; ALMEIDA, BIANCA DA SILVA - ICB ; SILVA, GUILHERME ANTONIO DE SOUZA - ICB ; MARQUES, RODOLFO FERREIRA - ICB ; SASAHARA, GREYCE LURI - FM ; SOARES, GUSTAVO HENRIQUE CORRÊA - ICB ; SANTOS, ROBERT ANDREATA - ICB ; MORETTI, ANA IOCHABEL SOARES - FM ; SILVA, MARIÂNGELA DE OLIVEIRA - ICB ; SCHUCH, VIVIANE - FCF ; Kalil, Jorge - FCF
- Unidades: ICB; FM; FCF
- DOI: 10.1016/j.clim.2025.110492
- Subjects: MICROBIOLOGIA; PARASITOLOGIA; VARIAÇÃO GENÉTICA; COVID-19; VACINAS VIRAIS; NEUTRALIZAÇÃO; CORONAVIRUS; VÍRUS DE RNA; INFECÇÕES POR VÍRUS DE RNA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Maryland Heights, MO
- Date published: 2025
- Source:
- Título: Clinical Immunology
- ISSN: 1521-7035
- Volume/Número/Paginação/Ano: v. 276, art. 110492, 12 p., 2025
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DAHER, Isabela Pazotti et al. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants. Clinical Immunology, v. 276, p. 12 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2025.110492. Acesso em: 14 jun. 2025. -
APA
Daher, I. P., Almeida, B. da S., Souza-Silva, G. A. de, Marques, R. F., Soares, G. H. C., Andreata-Santos, R., et al. (2025). Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants. Clinical Immunology, 276, 12 . doi:10.1016/j.clim.2025.110492 -
NLM
Daher IP, Almeida B da S, Souza-Silva GA de, Marques RF, Soares GHC, Andreata-Santos R, Moretti A, Silva M de O, Schuch V, Sasahara GL, Kuramoto A, Yamamoto M, Santos K, Coelho VPC de V, Kalil Filho JE, Rosa DS, Cunha Neto E, Ferreira LC de S, Boscardin SB. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants [Internet]. Clinical Immunology. 2025 ; 276 12 .[citado 2025 jun. 14 ] Available from: https://doi.org/10.1016/j.clim.2025.110492 -
Vancouver
Daher IP, Almeida B da S, Souza-Silva GA de, Marques RF, Soares GHC, Andreata-Santos R, Moretti A, Silva M de O, Schuch V, Sasahara GL, Kuramoto A, Yamamoto M, Santos K, Coelho VPC de V, Kalil Filho JE, Rosa DS, Cunha Neto E, Ferreira LC de S, Boscardin SB. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants [Internet]. Clinical Immunology. 2025 ; 276 12 .[citado 2025 jun. 14 ] Available from: https://doi.org/10.1016/j.clim.2025.110492 - Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity
- HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost
- A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses
- Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein
- Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine
- Poly(I:C)potentiates T cell immunity to a dendritic cell targeted HIV-multiepitope vaccine
- Análise da patologia molecular compartilhada e reposicionamento de fármacos para doenças inflamatórias crônicas sob a abordagem da medicina de redes
- Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
- Long non-coding RNAs associated with infection and vaccine-induced immunity
- ZnO-Based electrochemical immunosensor to assess vaccine-induced antibody-mediated immunity against Wild-Type and Gamma SARS-CoV-2 strains
Informações sobre o DOI: 10.1016/j.clim.2025.110492 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
